Financhill
Sell
40

PATH Quote, Financials, Valuation and Earnings

Last price:
$12.97
Seasonality move :
-1.3%
Day range:
$12.51 - $13.30
52-week range:
$10.37 - $27.87
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
5.30x
P/B ratio:
4.20x
Volume:
14.1M
Avg. volume:
10.8M
1-year change:
-46.44%
Market cap:
$7.3B
Revenue:
$1.3B
EPS (TTM):
-$0.16

Price Performance History

Performance vs. Valuation Benchmarks

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Competitors

Company Revenue Forecast Earnings Forecast Revenue Growth Forecast Earnings Growth Forecast Analyst Price Target Median
PATH
UiPath
$347.7M $0.07 4.98% 220.3% $15.18
CNXC
Concentrix
$2.4B $3.00 9.47% 181.84% --
DV
DoubleVerify Holdings
$168.9M $0.21 14.36% 66.07% $22.70
SABR
Sabre
$775.5M -$0.04 5.25% -56.52% $4.31
WYY
WidePoint
$30.4M -- 6.12% -- --
ZETA
Zeta Global Holdings
$252.5M $0.17 40.19% -- $37.77
Company Price Analyst Target Market Cap P/E Ratio Dividend per Share Dividend Yield Price / LTM Sales
PATH
UiPath
$13.25 $15.18 $7.3B -- $0.00 0% 5.30x
CNXC
Concentrix
$40.48 -- $2.6B 13.14x $0.33 3.06% 0.28x
DV
DoubleVerify Holdings
$19.96 $22.70 $3.3B 53.95x $0.00 0% 5.48x
SABR
Sabre
$3.86 $4.31 $1.5B -- $0.00 0% 0.49x
WYY
WidePoint
$4.63 -- $45.4M -- $0.00 0% 0.32x
ZETA
Zeta Global Holdings
$19.40 $37.77 $4.6B -- $0.00 0% 3.77x
Company Total Debt / Total Capital Beta Debt to Equity Quick Ratio
PATH
UiPath
-- 1.760 -- 2.90x
CNXC
Concentrix
54.67% 1.978 123.68% 1.18x
DV
DoubleVerify Holdings
-- 0.447 -- 6.30x
SABR
Sabre
144.79% -1.118 348.79% 0.92x
WYY
WidePoint
-- 4.683 -- 1.02x
ZETA
Zeta Global Holdings
29.23% -0.563 2.85% 3.26x
Company Gross Profit Operating Income Return on Invested Capital Return on Common Equity EBIT Margin Free Cash Flow
PATH
UiPath
$290.9M -$43.4M -4.78% -4.78% -12.23% $23.2M
CNXC
Concentrix
$857.6M $150.2M 3.4% 7.36% 7.12% $178.3M
DV
DoubleVerify Holdings
$140.1M $25.7M 6.09% 6.09% 17.66% $48.4M
SABR
Sabre
$231.2M $70.1M -8.52% -- 9.34% $7.6M
WYY
WidePoint
$4.7M -$451K -20.12% -20.12% -1.13% $1.8M
ZETA
Zeta Global Holdings
$162.6M -$7.8M -28.02% -49.55% -5.68% $25.6M

UiPath vs. Competitors

  • Which has Higher Returns PATH or CNXC?

    Concentrix has a net margin of -3% compared to UiPath's net margin of 2.81%. UiPath's return on equity of -4.78% beat Concentrix's return on equity of 7.36%.

    Company Gross Margin Earnings Per Share Invested Capital
    PATH
    UiPath
    82.02% -$0.02 $1.7B
    CNXC
    Concentrix
    36.02% $0.98 $9B
  • What do Analysts Say About PATH or CNXC?

    UiPath has a consensus price target of $15.18, signalling upside risk potential of 18.7%. On the other hand Concentrix has an analysts' consensus of -- which suggests that it could grow by 81.57%. Given that Concentrix has higher upside potential than UiPath, analysts believe Concentrix is more attractive than UiPath.

    Company Buy Ratings Hold Ratings Sell Ratings
    PATH
    UiPath
    2 20 1
    CNXC
    Concentrix
    0 0 0
  • Is PATH or CNXC More Risky?

    UiPath has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Concentrix has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.

  • Which is a Better Dividend Stock PATH or CNXC?

    UiPath has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Concentrix offers a yield of 3.06% to investors and pays a quarterly dividend of $0.33 per share. UiPath pays -- of its earnings as a dividend. Concentrix pays out 20.23% of its earnings as a dividend. Concentrix's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

  • Which has Better Financial Ratios PATH or CNXC?

    UiPath quarterly revenues are $354.7M, which are smaller than Concentrix quarterly revenues of $2.4B. UiPath's net income of -$10.7M is lower than Concentrix's net income of $66.8M. Notably, UiPath's price-to-earnings ratio is -- while Concentrix's PE ratio is 13.14x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for UiPath is 5.30x versus 0.28x for Concentrix. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    PATH
    UiPath
    5.30x -- $354.7M -$10.7M
    CNXC
    Concentrix
    0.28x 13.14x $2.4B $66.8M
  • Which has Higher Returns PATH or DV?

    DoubleVerify Holdings has a net margin of -3% compared to UiPath's net margin of 10.74%. UiPath's return on equity of -4.78% beat DoubleVerify Holdings's return on equity of 6.09%.

    Company Gross Margin Earnings Per Share Invested Capital
    PATH
    UiPath
    82.02% -$0.02 $1.7B
    DV
    DoubleVerify Holdings
    82.61% $0.10 $1.1B
  • What do Analysts Say About PATH or DV?

    UiPath has a consensus price target of $15.18, signalling upside risk potential of 18.7%. On the other hand DoubleVerify Holdings has an analysts' consensus of $22.70 which suggests that it could grow by 13.73%. Given that UiPath has higher upside potential than DoubleVerify Holdings, analysts believe UiPath is more attractive than DoubleVerify Holdings.

    Company Buy Ratings Hold Ratings Sell Ratings
    PATH
    UiPath
    2 20 1
    DV
    DoubleVerify Holdings
    6 5 1
  • Is PATH or DV More Risky?

    UiPath has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison DoubleVerify Holdings has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.

  • Which is a Better Dividend Stock PATH or DV?

    UiPath has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. DoubleVerify Holdings offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. UiPath pays -- of its earnings as a dividend. DoubleVerify Holdings pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios PATH or DV?

    UiPath quarterly revenues are $354.7M, which are larger than DoubleVerify Holdings quarterly revenues of $169.6M. UiPath's net income of -$10.7M is lower than DoubleVerify Holdings's net income of $18.2M. Notably, UiPath's price-to-earnings ratio is -- while DoubleVerify Holdings's PE ratio is 53.95x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for UiPath is 5.30x versus 5.48x for DoubleVerify Holdings. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    PATH
    UiPath
    5.30x -- $354.7M -$10.7M
    DV
    DoubleVerify Holdings
    5.48x 53.95x $169.6M $18.2M
  • Which has Higher Returns PATH or SABR?

    Sabre has a net margin of -3% compared to UiPath's net margin of -8.22%. UiPath's return on equity of -4.78% beat Sabre's return on equity of --.

    Company Gross Margin Earnings Per Share Invested Capital
    PATH
    UiPath
    82.02% -$0.02 $1.7B
    SABR
    Sabre
    30.23% -$0.16 $3.5B
  • What do Analysts Say About PATH or SABR?

    UiPath has a consensus price target of $15.18, signalling upside risk potential of 18.7%. On the other hand Sabre has an analysts' consensus of $4.31 which suggests that it could grow by 17.58%. Given that UiPath has higher upside potential than Sabre, analysts believe UiPath is more attractive than Sabre.

    Company Buy Ratings Hold Ratings Sell Ratings
    PATH
    UiPath
    2 20 1
    SABR
    Sabre
    3 5 0
  • Is PATH or SABR More Risky?

    UiPath has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Sabre has a beta of 1.799, suggesting its more volatile than the S&P 500 by 79.894%.

  • Which is a Better Dividend Stock PATH or SABR?

    UiPath has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Sabre offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. UiPath pays -- of its earnings as a dividend. Sabre pays out -3.04% of its earnings as a dividend.

  • Which has Better Financial Ratios PATH or SABR?

    UiPath quarterly revenues are $354.7M, which are smaller than Sabre quarterly revenues of $764.7M. UiPath's net income of -$10.7M is higher than Sabre's net income of -$62.8M. Notably, UiPath's price-to-earnings ratio is -- while Sabre's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for UiPath is 5.30x versus 0.49x for Sabre. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    PATH
    UiPath
    5.30x -- $354.7M -$10.7M
    SABR
    Sabre
    0.49x -- $764.7M -$62.8M
  • Which has Higher Returns PATH or WYY?

    WidePoint has a net margin of -3% compared to UiPath's net margin of -1.23%. UiPath's return on equity of -4.78% beat WidePoint's return on equity of -20.12%.

    Company Gross Margin Earnings Per Share Invested Capital
    PATH
    UiPath
    82.02% -$0.02 $1.7B
    WYY
    WidePoint
    13.55% -$0.04 $13.8M
  • What do Analysts Say About PATH or WYY?

    UiPath has a consensus price target of $15.18, signalling upside risk potential of 18.7%. On the other hand WidePoint has an analysts' consensus of -- which suggests that it could grow by 40.39%. Given that WidePoint has higher upside potential than UiPath, analysts believe WidePoint is more attractive than UiPath.

    Company Buy Ratings Hold Ratings Sell Ratings
    PATH
    UiPath
    2 20 1
    WYY
    WidePoint
    0 0 0
  • Is PATH or WYY More Risky?

    UiPath has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison WidePoint has a beta of 1.716, suggesting its more volatile than the S&P 500 by 71.645%.

  • Which is a Better Dividend Stock PATH or WYY?

    UiPath has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. WidePoint offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. UiPath pays -- of its earnings as a dividend. WidePoint pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios PATH or WYY?

    UiPath quarterly revenues are $354.7M, which are larger than WidePoint quarterly revenues of $34.6M. UiPath's net income of -$10.7M is lower than WidePoint's net income of -$425.2K. Notably, UiPath's price-to-earnings ratio is -- while WidePoint's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for UiPath is 5.30x versus 0.32x for WidePoint. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    PATH
    UiPath
    5.30x -- $354.7M -$10.7M
    WYY
    WidePoint
    0.32x -- $34.6M -$425.2K
  • Which has Higher Returns PATH or ZETA?

    Zeta Global Holdings has a net margin of -3% compared to UiPath's net margin of -6.48%. UiPath's return on equity of -4.78% beat Zeta Global Holdings's return on equity of -49.55%.

    Company Gross Margin Earnings Per Share Invested Capital
    PATH
    UiPath
    82.02% -$0.02 $1.7B
    ZETA
    Zeta Global Holdings
    60.62% -$0.09 $671M
  • What do Analysts Say About PATH or ZETA?

    UiPath has a consensus price target of $15.18, signalling upside risk potential of 18.7%. On the other hand Zeta Global Holdings has an analysts' consensus of $37.77 which suggests that it could grow by 94.69%. Given that Zeta Global Holdings has higher upside potential than UiPath, analysts believe Zeta Global Holdings is more attractive than UiPath.

    Company Buy Ratings Hold Ratings Sell Ratings
    PATH
    UiPath
    2 20 1
    ZETA
    Zeta Global Holdings
    8 4 0
  • Is PATH or ZETA More Risky?

    UiPath has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Zeta Global Holdings has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.

  • Which is a Better Dividend Stock PATH or ZETA?

    UiPath has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Zeta Global Holdings offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. UiPath pays -- of its earnings as a dividend. Zeta Global Holdings pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios PATH or ZETA?

    UiPath quarterly revenues are $354.7M, which are larger than Zeta Global Holdings quarterly revenues of $268.3M. UiPath's net income of -$10.7M is higher than Zeta Global Holdings's net income of -$17.4M. Notably, UiPath's price-to-earnings ratio is -- while Zeta Global Holdings's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for UiPath is 5.30x versus 3.77x for Zeta Global Holdings. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    PATH
    UiPath
    5.30x -- $354.7M -$10.7M
    ZETA
    Zeta Global Holdings
    3.77x -- $268.3M -$17.4M

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret

It’s not often that a company with the scale and…

Will Tyson Foods Stock Bounce Back?
Will Tyson Foods Stock Bounce Back?

Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…

Will Iovance Biotherapeutics Stock Bounce Back?
Will Iovance Biotherapeutics Stock Bounce Back?

Iovance Biotherapeutics (NASDAQ:IOVA) is a fledgling pharmaceutical company that specializes…

Stock Ideas

Buy
64
Is AAPL Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 42x

Buy
52
Is NVDA Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 113x

Buy
55
Is MSFT Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 37x

Alerts

Buy
61
QMCO alert for Dec 23

Quantum [QMCO] is up 5.45% over the past day.

Sell
46
NUKK alert for Dec 23

Nukkleus [NUKK] is up 8.95% over the past day.

Sell
1
IIPR alert for Dec 23

Innovative Industrial Properties [IIPR] is down 3.34% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock